眼科画像市場規模、セグメント分析、2030年までの予測

本レポートは、眼科画像市場を評価し、製品、アプリケーション、エンドユーザー、地域など、様々なセグメントに基づいて、その規模と将来の成長可能性を予測しています。また、主要プレーヤーの競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略も掲載しています。

本レポートは、眼科画像市場全体および各サブセグメントの収益数値の近似値に関するデータを提供し、市場リーダー／新規参入企業を支援します。また、ステークホルダーが競争環境を理解し、事業のより良い位置付けと適切な市場開拓戦略の策定に役立つ洞察を得るのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、市場に影響を与える推進要因、阻害要因、障壁、そして機会に関するデータを提供するのに役立ちます。

眼科画像市場は、予測期間中に6.3%のCAGRで成長し、2025年の28億3,000万米ドルから2030年には38億4,000万米ドルに達すると予測されています。

眼科画像市場は、緑内障、糖尿病網膜症、加齢黄斑変性症といった眼疾患の増加に牽引されており、特に世界的な高齢化が進んでいます。早期かつ正確な診断への需要の高まり、OCTや眼底カメラといった画像診断技術の進歩、そして予防眼科ケアへの意識の高まりが市場の成長を後押ししています。さらに、政府の積極的な施策や医療費の増加も市場拡大を支えています。しかしながら、機器価格の高さ、特定地域における償還制限、そして熟練した医療従事者の不足が、特に低所得地域や農村部での普及を阻んでいます。また、臨床ワークフローにおけるデータ管理・統合の課題も、一部の医療施設の効率性をさらに阻害しています。AIを統合したポータブル画像診断装置の開発と、十分な医療サービスを受けられていない人々への遠隔眼科医療サービスの拡大に、ビジネスチャンスが存在します。

The ophthalmic imaging market is projected to reach USD 3.84 billion by 2030 from USD 2.83 billion in 2025, at a CAGR of 6.3% during the forecast period.

The ophthalmic imaging market is driven by the growing prevalence of eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration, particularly among the aging global population. Increasing demand for early and accurate diagnosis, advancements in imaging technologies like OCT and fundus cameras, and rising awareness of preventive eye care are boosting market growth. Additionally, favorable government initiatives and rising healthcare expenditure support market expansion. However, high equipment costs, limited reimbursement in certain regions, and a shortage of skilled professionals restrain widespread adoption, especially in low-income and rural settings. Data management and integration challenges in clinical workflows further limit efficiency in some healthcare facilities. Opportunities lie in the development of portable, AI-integrated imaging devices and the expansion of teleophthalmology services to reach underserved populations.

Based on product, the OCT systems segment is expected to have the highest growth rate during the forecast year. Optical coherence tomography (OCT) systems are expected to grow at the highest CAGR during the forecast period because they offer non‑invasive, ultra‑high-resolution imaging essential for early diagnosis of retinal and optic nerve diseases. Technological advances—such as swept‑source OCT, OCT-angiography, and AI‑driven analytics—enhance diagnostic capability and workflow efficiency. Compact, handheld OCT devices are expanding access in primary care and rural settings. The growing global prevalence of diabetes, glaucoma, and AMD, combined with rising healthcare investments and favorable reimbursements, further drives OCT adoption and rapid market expansion.

Based on end user, the optometry clinics segment is expected to have the highest growth rate during the forecast year due to increasing consumer awareness of eye health and routine vision screenings. They serve as primary care hubs, offering accessible and affordable eye examinations. The rising adoption of portable, high-resolution diagnostic devices such as OCT, fundus cameras, and visual field analyzers in clinics further accelerates this trend. Clinics are increasingly investing in AI-enabled, compact equipment to enhance workflow efficiency and deliver rapid diagnostics. Additionally, growth in tele-optometry and remote screening models supports scalable reach, particularly in underserved regions, driving sustained clinic-based expansion.

Asia Pacific is expected to have the highest growth rate during the forecast period due to a rapidly aging population, rising prevalence of eye disorders like glaucoma, cataracts, and diabetic retinopathy, and increasing investment in healthcare infrastructure across key countries like China and India. Governments are expanding access via teleophthalmology networks and mobile clinics, while local innovation and affordable device production enhance adoption in underserved areas. Technological adoption, particularly OCT, AI tools, and multimodal platforms, is accelerating region-wide growth.

A breakdown of the primary participants (supply-side) for the ophthalmic imaging market referred to in this report is provided below:

• By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
• By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
• By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the ophthalmic imaging market are Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Nidek Co. Ltd. (Japan), Alcon Inc. (Switzerland), Optopol Technology Sp. z o.o (Poland), Essilor International S.A. (France), Bausch & Lomb Incorporated (US), and Halma Plc (UK),  among others.

Research Coverage

The report evaluates the ophthalmic imaging market and estimates its size and future growth potential based on various segments, including products, applications, end users, and regions. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants in the market with data on the nearest approximations of the revenue numbers for the overall ophthalmic imaging market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better placing their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

Analysis of key drivers (Rising number of preterm and low-weight births, Public-private initiatives to strengthen patient care, Increasing incidence of HAIs among newborns, Changing clinical risks for congenital and obstetric complications, Rising number of neonatal care facilities worldwide), restraints (Premium pricing of advanced neonatal care equipment, Growing preference for refurbished devices across emerging countries), opportunities (Development of integrated and multifunctional neonatal care equipment, Market opportunities in emerging markets) and challenges (Limited access in low-income regions, Regulatory and compliance complexities)

• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ophthalmic imaging market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ophthalmic imaging market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ophthalmic imaging market

Table of Contents

1               INTRODUCTION              33

1.1           STUDY OBJECTIVES       33

1.2           MARKET DEFINITION   33

1.3           STUDY SCOPE   34

1.3.1        OPHTHALMIC IMAGING MARKET SEGMENTATION & REGIONAL SCOPE            34

1.3.2        INCLUSIONS & EXCLUSIONS       35

1.3.3        YEARS CONSIDERED      36

1.3.4        CURRENCY CONSIDERED            36

1.4           STAKEHOLDERS               37

2               RESEARCH METHODOLOGY       38

2.1           RESEARCH DATA              38

2.1.1        SECONDARY DATA          38

2.1.1.1    Key sources of secondary data            39

2.1.1.2    Key data from secondary sources       40

2.1.2        PRIMARY DATA 40

2.1.2.1    Key sources of primary data                40

2.1.2.2    Key objectives of primary research    41

2.1.2.3    Key data from primary sources           41

2.1.2.4    Key industry insights           42

2.1.2.5    Breakdown of primary interviews      42

2.2           MARKET SIZE ESTIMATION         44

2.2.1        SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)                 44

2.2.1.1    Company presentations and primary interviews              45

2.2.1.2    Demand-side analysis          46

2.2.1.3    Top-down approach             48

2.3           DATA TRIANGULATION                49

2.4           MARKET SHARE ESTIMATION    50

2.5           STUDY ASSUMPTIONS  51

2.6           RESEARCH LIMITATIONS             51

2.7           RISK ANALYSIS  52

3               EXECUTIVE SUMMARY  53

4               PREMIUM INSIGHTS       57

4.1           OPHTHALMIC IMAGING MARKET OVERVIEW    57

4.2           ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY AND COUNTRY (2024)     58

4.3           OPHTHALMIC IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         59

4.4           OPHTHALMIC IMAGING MARKET, REGIONAL MIX, 2023−2030            59

4.5           OPHTHALMIC IMAGING MARKET: EMERGING VS. DEVELOPED MARKETS 60

5               MARKET OVERVIEW       61

5.1           INTRODUCTION              61

5.2           MARKET DYNAMICS       61

5.2.1        DRIVERS               62

5.2.1.1    Growing prevalence of chronic eye diseases among geriatric patients  62

5.2.1.2    Technological advancements in imaging modalities       63

5.2.1.3    Favorable government initiatives and better reimbursement support   63

5.2.2        RESTRAINTS      64

5.2.2.1    High capital cost of ophthalmic imaging equipment      64

5.2.2.2    High maintenance costs and increased downtime of high-end systems  64

5.2.3        OPPORTUNITIES              64

5.2.3.1    High growth opportunities in emerging economies        64

5.2.3.2    Focus on AI-enabled screening and workflow optimization                 65

5.2.4        CHALLENGES    65

5.2.4.1    Shortage of skilled ophthalmic technicians and clinicians                 65

5.2.4.2    Data privacy and AI regulation challenges       66

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       66

5.4           PRICING ANALYSIS          67

5.4.1        AVERAGE SELLING PRICE OF OPHTHALMIC IMAGING PRODUCTS, BY TYPE, 2024           67

5.4.2        AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024                 68

5.5           VALUE CHAIN ANALYSIS               69

5.6           SUPPLY CHAIN ANALYSIS             70

5.7           ECOSYSTEM ANALYSIS  71

5.7.1        ROLE IN ECOSYSTEM     72

5.8           INVESTMENT & FUNDING SCENARIO     73

5.9           TECHNOLOGY ANALYSIS             75

5.9.1        KEY TECHNOLOGIES     75

5.9.1.1    Fluorescein angiography     75

5.9.1.2    Ultrasound B-scan imaging                 75

5.9.2        COMPLEMENTARY TECHNOLOGIES       75

5.9.2.1    Artificial intelligence and deep learning           75

5.9.3        ADJACENT TECHNOLOGIES       76

5.9.3.1    Smartphone-based retinal imaging    76

5.9.3.2    Gene therapy & retinal implants        76

5.10         INDUSTRY TRENDS         76

5.10.1      RAPID SHIFT TOWARD MULTIMODAL AND AI-INTEGRATED IMAGING SYSTEMS             76

5.10.2      INCREASED PENETRATION OF PORTABLE AND HANDHELD IMAGING SOLUTIONS          77

5.10.3      PREMIUM IMAGING GROWTH TO GET HIGH CAPITAL INVESTMENTS IN HOSPITALS AND TERTIARY CARE CENTERS                 77

5.10.4      OEM CONSOLIDATION AND SOFTWARE-DRIVEN ECOSYSTEMS TO RESHAPE COMPETITIVE LANDSCAPE 77

5.11         PATENT ANALYSIS          77

5.12         TRADE ANALYSIS             79

5.12.1      IMPORT DATA FOR HS CODE 901850, 2020–2024  79

5.12.2      EXPORT DATA FOR HS CODE 901850, 2020–2024  80

5.13         KEY CONFERENCES & EVENTS, 2025–2026              81

5.14         CASE STUDY ANALYSIS 82

5.14.1      ZEISS TO ENHANCE CIRRUS HD-OCT PLATFORM BY INTEGRATING AI-BASED TOOLS FOR DETECTING GLAUCOMA AND RETINAL DISEASES               82

5.14.2      INDIA’S NATIONAL PROGRAM FOR CONTROL OF BLINDNESS (NPCB) TO COLLABORATE WITH FORUS HEALTH FOR REDUCING AVOIDABLE BLINDNESS              82

5.14.3      UK NATIONAL HEALTH SERVICE TO DEPLOY HEIDELBERG ENGINEERING’S SPECTRALIS OCT PLATFORM FOR IMPROVING EARLY DETECTION OF CHRONIC DISEASES                 83

5.15         REGULATORY ANALYSIS               83

5.15.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             83

5.15.2      REGULATORY FRAMEWORK       85

5.15.2.1  North America      85

5.15.2.1.1                US           85

5.15.2.1.2                Canada   86

5.15.2.2  Europe   86

5.15.2.2.1                Germany                 86

5.15.2.2.2                France    86

5.15.2.2.3                UK          86

5.15.2.3  Asia Pacific            86

5.15.2.3.1                China      86

5.15.2.3.2                Japan      87

5.15.2.3.3                India       87

5.15.2.4  Latin America       87

5.15.2.4.1                Brazil      87

5.15.2.4.2                Mexico   87

5.15.2.5  Middle East & Africa            87

5.15.2.5.1                Saudi Arabia          87

5.15.2.5.2                UAE        88

5.15.2.5.3                South Africa           88

5.15.2.5.4                Nigeria   88

5.16         PORTER’S FIVE FORCES ANALYSIS           88

5.16.1      BARGAINING POWER OF SUPPLIERS       90

5.16.2      BARGAINING POWER OF BUYERS             90

5.16.3      THREAT OF NEW ENTRANTS      90

5.16.4      THREAT OF SUBSTITUTES          90

5.16.5      INTENSITY OF COMPETITIVE RIVALRY 90

5.17         KEY STAKEHOLDERS & BUYING CRITERIA            91

5.17.1      KEY STAKEHOLDERS IN BUYING PROCESS           91

5.17.2      KEY BUYING CRITERIA  92

5.18         UNMET NEEDS/END-USER EXPECTATIONS         92

5.19         IMPACT OF 2025 US TARIFF ON OPHTHALMIC IMAGING MARKET               94

5.19.1      KEY TARIFF RATES          95

5.19.2      PRICE IMPACT ANALYSIS             96

5.19.3      KEY IMPACT ON COUNTRY/REGION      96

5.19.3.1  North America      96

5.19.3.1.1                US           96

5.19.3.2  Europe   97

5.19.3.3  Asia Pacific            97

5.19.4      IMPACT ON END-USE INDUSTRIES          97

5.20         IMPACT OF AI/ GEN AI ON OPHTHALMIC IMAGING MARKET               97

5.21         ADJACENT MARKET ANALYSIS  98

6               OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY                 99

6.1           INTRODUCTION              100

6.2           AI-ENABLED EQUIPMENT            100

6.2.1        RISING DEMAND FOR EARLY DIAGNOSIS, EFFICIENCY, AND STANDARDIZATION TO DRIVE MARKET    100

6.3           NON-AI-ENABLED EQUIPMENT 104

6.3.1        ESTABLISHED CLINICAL UTILITY AND COST-EFFECTIVENESS TO SUSTAIN DOMINANCE         104

7               OPHTHALMIC IMAGING MARKET, BY PRODUCT                 106

7.1           INTRODUCTION              107

7.2           OPTICAL COHERENCE TOMOGRAPHY SYSTEMS                 107

7.2.1        SPECTRAL-DOMAIN OCT (SD-OCT)        109

7.2.1.1    Growing demand for high-resolution retinal imaging to accelerate market adoption 109

7.2.2        SWEPT-SOURCE OCT (SS-OCT) 110

7.2.2.1    Rising preference for deep tissue imaging and faster scanning to fuel market growth                110

7.2.3        HANDHELD OCT              112

7.2.3.1    Surging demand for portability and pediatric imaging to propel market growth       112

7.3           OPHTHALMIC ULTRASOUND SYSTEMS 113

7.3.1        OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS                 115

7.3.1.1    Rising prevalence of cataracts and increasing intraocular lens (IOL) implantation procedures to aid market growth    115

7.3.2        OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS                 116

7.3.2.1    Rising incidence of retinal disorders and opaque media cases to augment segment growth    116

7.3.3        OPHTHALMIC ULTRASOUND BIOMICROSCOPES                 118

7.3.3.1    Demand for high-resolution anterior segment imaging to fuel market growth       118

7.3.4        OPHTHALMIC PACHYMETERS   119

7.3.4.1    Growing incidence of glaucoma and increasing demand for refractive surgery to support segment growth 119

7.3.5        OTHER OPHTHALMIC ULTRASOUND SYSTEMS 121

7.4           FUNDUS CAMERAS          122

7.4.1        MYDRIATIC FUNDUS CAMERAS 124

7.4.1.1    Advancements in retinal disease diagnosis and imaging precision to boost market growth        124

7.4.2        NON-MYDRIATIC FUNDUS CAMERAS     126

7.4.2.1    Rising diabetic retinopathy screening and growing focus on primary eye care to augment market growth    126

7.4.3        HYBRID FUNDUS CAMERAS         127

7.4.3.1    Demand for versatile retinal imaging and workflow efficiency to fuel market adoption            127

7.4.4        ROP FUNDUS CAMERAS                129

7.4.4.1    Urgent need for early detection of retinal disorders in newborns to propel segment growth   129

7.5           SLIT LAMPS        130

7.5.1        HANDHELD SLIT LAMPS               132

7.5.1.1    Portability, tele-ophthalmology, and field screening to fuel market demand     132

7.5.2        TABLE MOUNT SLIT LAMPS        134

7.5.2.1    Focus on precision diagnostics and need for better image clarity to augment market growth  134

7.6           SPECULAR MICROSCOPES           135

7.6.1        RISING NUMBER OF CORNEAL TRANSPLANTS AND CATARACT SURGERIES TO ACCELERATE MARKET DEMAND                 135

7.7           TONOMETERS  137

7.7.1        APPLANATION TONOMETERS   139

7.7.1.1    Widespread clinical acceptance and diagnostic accuracy to aid market growth       139

7.7.2        REBOUND TONOMETERS            140

7.7.2.1    Adoption of rebound tonometers to gain preference for better portability and greater patient comfort             140

7.8           OPHTHALMOSCOPES    142

7.8.1        DIRECT OPHTHALMOSCOPES   144

7.8.1.1    Technological upgrades to sustain global demand for direct ophthalmoscopes  144

7.8.2        INDIRECT OPHTHALMOSCOPES               145

7.8.2.1    Growing demand in retinal care to increase product demand                 145

7.9           RETINOSCOPES                147

7.9.1        RISING DEMAND AMONG PEDIATRIC, NON-VERBAL, AND UNCOOPERATIVE PATIENTS TO SUSTAIN DEMAND                 147

7.10         OTHER OPHTHALMIC IMAGING PRODUCTS       149

8               OPHTHALMIC IMAGING MARKET, BY APPLICATION                 151

8.1           INTRODUCTION              152

8.2           GLAUCOMA        152

8.2.1        NEED FOR EARLY DETECTION AND LONG-TERM MONITORING TO FUEL ADOPTION OF ADVANCED IMAGING MODALITIES     152

8.3           CATARACTS       153

8.3.1        INCREASING CATARACT SURGERIES AND PREOPERATIVE IMAGING TO SPUR DEMAND FOR DIAGNOSTIC OPHTHALMIC SYSTEMS                153

8.4           RETINOPATHIES              155

8.4.1        RISING DIABETIC AND HYPERTENSIVE POPULATION TO ACCELERATE DEMAND FOR ADVANCED RETINAL IMAGING SOLUTIONS        155

8.5           REFRACTIVE DISORDERS             156

8.5.1        RISING DEMAND FOR REFRACTIVE SURGERIES TO BOOST UPTAKE OF ADVANCED IMAGING SYSTEMS FOR PREOPERATIVE PLANNING         156

8.6           AGE-RELATED MACULAR DEGENERATION         157

8.6.1        AGING DEMOGRAPHICS AND INCREASED LIFESPAN TO PROPEL PREVALENCE OF AGE-RELATED MACULAR DEGENERATION              157

8.7           OTHER APPLICATIONS 158

9               OPHTHALMIC IMAGING MARKET, BY END USER                 159

9.1           INTRODUCTION              160

9.2           HOSPITALS         160

9.2.1        RISING ADOPTION OF ADVANCED OPHTHALMIC DIAGNOSTICS TO AUGMENT MARKET GROWTH              160

9.3           OPHTHALMOLOGY CLINICS       161

9.3.1        USE OF HIGH-THROUGHPUT, AI-INTEGRATED, AND PORTABLE IMAGING DEVICES TO FUEL MARKET GROWTH                 161

9.4           OPTOMETRY CLINICS   163

9.4.1        INCREASING PREVALENCE OF MYOPIA AND LIFESTYLE-RELATED VISION DISORDERS TO AID MARKET GROWTH                 163

9.5           OTHER END USERS         164

10            OPHTHALMIC IMAGING MARKET, BY REGION   165

10.1         INTRODUCTION              166

10.2         NORTH AMERICA             166

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 167

10.2.2      US           172

10.2.2.1  US to dominate North American ophthalmic imaging market during forecast period          172

10.2.3      CANADA               177

10.2.3.1  Rising geriatric population with chronic eye diseases to propel market growth       177

10.3         EUROPE               181

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      181

10.3.2      GERMANY           186

10.3.2.1  Strong clinical infrastructure and favorable healthcare policies to boost market growth             186

10.3.3      FRANCE                191

10.3.3.1  Government-funded eye screening programs and widespread insurance coverage to accelerate market growth              191

10.3.4      UK          195

10.3.4.1  Popularity on national screening programs and focus on NHS-backed digital adoption to stabilize market growth         195

10.3.5      ITALY    200

10.3.5.1  High geriatric population and expansion of regional eye care programs to boost demand for ophthalmic imaging       200

10.3.6      SPAIN    204

10.3.6.1  Increased public investment in health screening programs to aid market growth       204

10.3.7      REST OF EUROPE             209

10.4         ASIA PACIFIC     213

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 213

10.4.2      JAPAN   219

10.4.2.1  Strong focus on preventive and advanced eye care infrastructure to augment market growth  219

10.4.3      CHINA  224

10.4.3.1  Popularity of large-scale eye screening programs and focus on advanced ophthalmic imaging infrastructure to drive market       224

10.4.4      INDIA    228

10.4.4.1  Rising diabetic population and increasing popularity of nationwide eye health programs to propel market growth             228

10.4.5      SOUTH KOREA  233

10.4.5.1  High-tech healthcare adoption and aging demographics to accelerate smart ophthalmic imaging integration            233

10.4.6      AUSTRALIA         237

10.4.6.1  Government-backed eye care programs and expanding teleophthalmology to propel market growth    237

10.4.7      REST OF ASIA PACIFIC   242

10.5         LATIN AMERICA                246

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 246

10.5.2      BRAZIL 251

10.5.2.1  Focus on public tele-ophthalmology initiatives and diagnostics to boost market growth             251

10.5.3      MEXICO                256

10.5.3.1  Increasing prevalence of diabetic eye disease and growing focus on digital health expansion to drive market     256

10.5.4      REST OF LATIN AMERICA             260

10.6         MIDDLE EAST & AFRICA                264

10.6.1      INCREASED HEALTHCARE MODERNIZATION AND FOCUS ON PUBLIC HEALTH INVESTMENTS TO AID MARKET GROWTH             264

10.6.2      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 264

10.7         GCC COUNTRIES              269

10.7.1      GOVERNMENT-LED HEALTHCARE DIGITALIZATION AND INCREASED DIABETES-LINKED VISION DISORDERS TO DRIVE MARKET 269

10.7.2      MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 269

11            COMPETITIVE LANDSCAPE         274

11.1         INTRODUCTION              274

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            274

11.2.1      KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN OPHTHALMIC IMAGING MARKET            274

11.3         REVENUE ANALYSIS, 2020–2024  276

11.4         MARKET SHARE ANALYSIS, 2024                 277

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 278

11.5.1      STARS   278

11.5.2      EMERGING LEADERS     278

11.5.3      PERVASIVE PLAYERS      279

11.5.4      PARTICIPANTS 279

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         280

11.5.5.1  Company footprint               280

11.5.5.2  Region footprint   281

11.5.5.3  Product footprint  282

11.5.5.4  Application footprint            283

11.5.5.5  End-user footprint                284

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        285

11.6.1      PROGRESSIVE COMPANIES         285

11.6.2      RESPONSIVE COMPANIES            285

11.6.3      DYNAMIC COMPANIES  285

11.6.4      STARTING BLOCKS         285

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 287

11.6.5.1  Detailed list of key startups/SMEs    287

11.6.5.2  Competitive benchmarking of startups/SMEs 288

11.7         COMPANY VALUATION & FINANCIAL METRICS 289

11.7.1      FINANCIAL METRICS      289

11.7.2      COMPANY VALUATION 289

11.8         BRAND/PRODUCT COMPARISON             290

11.9         COMPETITIVE SCENARIO             291

11.9.1      PRODUCT LAUNCHES   291

11.9.2      DEALS  292

11.9.3      OTHER DEVELOPMENTS              292

12            COMPANY PROFILES      293

12.1         KEY PLAYERS     293

12.1.1      CARL ZEISS MEDITEC AG              293

12.1.1.1  Business overview 293

12.1.1.2  Products offered   294

12.1.1.3  Recent developments           295

12.1.1.3.1                Product launches & upgrades             295

12.1.1.3.2                Deals      295

12.1.1.4  MnM view              295

12.1.1.4.1                Right to win           295

12.1.1.4.2                Strategic choices   296

12.1.1.4.3                Weaknesses & competitive threats     296

12.1.2      TOPCON CORPORATION              297

12.1.2.1  Business overview 297

12.1.2.2  Products offered   298

12.1.2.3  Recent developments           299

12.1.2.3.1                Deals      299

12.1.2.3.2                Other developments             299

12.1.2.4  MnM view              299

12.1.2.4.1                Right to win           299

12.1.2.4.2                Strategic choices   300

12.1.2.4.3                Weaknesses & competitive threats     300

12.1.3      NIDEK CO., LTD.               301

12.1.3.1  Business overview 301

12.1.3.2  Products offered   301

12.1.3.3  MnM view              302

12.1.3.3.1                Right to win           302

12.1.3.3.2                Strategic choices   302

12.1.3.3.3                Weaknesses & competitive threats     302

12.1.4      HALMA PLC        303

12.1.4.1  Business overview 303

12.1.4.2  Products offered   305

12.1.4.3  MnM view              306

12.1.4.3.1                Right to win           306

12.1.4.3.2                Strategic choices   306

12.1.4.3.3                Weaknesses & competitive threats     306

12.1.5      ALCON 307

12.1.5.1  Business overview 307

12.1.5.2  Products offered   308

12.1.5.3  MnM view              308

12.1.5.3.1                Right to win           308

12.1.5.3.2                Strategic choices   308

12.1.5.3.3                Weaknesses & competitive threats     309

12.1.6      HEIDELBERG ENGINEERING GMBH         310

12.1.6.1  Business overview 310

12.1.6.2  Products offered   310

12.1.7      HAAG-STREIT GROUP   311

12.1.7.1  Business overview 311

12.1.7.2  Products offered   311

12.1.8      CANON MEDICAL SYSTEMS CORPORATION        312

12.1.8.1  Business overview 312

12.1.8.2  Products offered   313

12.1.9      ESSILORLUXOTTICA      314

12.1.9.1  Business overview 314

12.1.9.2  Products offered   314

12.1.10   OCULUS               315

12.1.10.1                 Business overview 315

12.1.10.2                 Products offered   315

12.1.10.3                 Recent developments           316

12.1.10.3.1             Product launches  316

12.1.11   VISIONIX              317

12.1.11.1                 Business overview 317

12.1.11.2                 Products offered   317

12.1.11.3                 Recent developments           318

12.1.11.3.1             Deals      318

12.1.12   SONOMED ESCALON     319

12.1.12.1                 Business overview 319

12.1.12.2                 Products offered   319

12.1.13   COBURN TECHNOLOGIES, INC. 320

12.1.13.1                 Business overview 320

12.1.13.2                 Products offered   320

12.1.13.3                 Recent developments           321

12.1.13.3.1             Product launches  321

12.1.14   DGH TECHNOLOGY, INC.             322

12.1.14.1                 Business overview 322

12.1.14.2                 Products offered   322

12.1.15  SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.      323

12.1.15.1                 Business overview 323

12.1.15.2                 Products offered   323

12.2         OTHER PLAYERS              324

12.2.1      VISUNEX MEDICAL SYSTEMS      324

12.2.2      FORUS HEALTH PVT. LTD.          325

12.2.3      ZIEMER OPHTHALMIC SYSTEMS AG        326

12.2.4      EYENUK INC.     327

12.2.5      COSTRUZIONE STRUMENTI OFTALMICI (CSO)  328

12.2.6      HAI LABORATORIES, INC.             329

12.2.7      CRYSTALVUE MEDICAL CORPORATION                330

12.2.8      SUZHOU KANGJIE MEDICAL INC.              331

12.2.9      KONAN MEDICAL USA, INC.        332

12.2.10   REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.  333

13            APPENDIX           334

13.1         DISCUSSION GUIDE        334

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                340

13.3         CUSTOMIZATION OPTIONS        342

13.4         RELATED REPORTS         342

13.5         AUTHOR DETAILS           343

LIST OF TABLES

TABLE 1                OPHTHALMIC IMAGING MARKET: INCLUSIONS & EXCLUSIONS 35

TABLE 2                STANDARD CURRENCY CONVERSION RATES FROM USD, 2020–2024     36

TABLE 3                OPHTHALMIC IMAGING MARKET: STUDY ASSUMPTIONS  51

TABLE 4                OPHTHALMIC IMAGING MARKET: RISK ANALYSIS            52

TABLE 5                OPHTHALMIC IMAGING MARKET: IMPACT OF ANALYSIS OF MARKET DYNAMICS           62

TABLE 6                AVERAGE SELLING PRICE OF OPHTHALMIC IMAGING PRODUCTS,

BY TYPE, 2024 (USD)       67

TABLE 7                AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD)    68

TABLE 8                OPHTHALMIC IMAGING MARKET: ROLE IN ECOSYSTEM       72

TABLE 9                IMPORT DATA FOR HS CODE 901850, BY COUNTRY,

2020–2024 (USD THOUSAND)      79

TABLE 10              EXPORT DATA FOR HS CODE 901890, BY COUNTRY,

2020–2024 (USD THOUSAND)      80

TABLE 11              OPHTHALMIC IMAGING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANAURY 2025–DECEMBER 2026                 81

TABLE 12              CASE STUDY 1: ZEISS TO ENHANCE CIRRUS HD-OCT PLATFORM BY INTEGRATING AI-BASED TOOLS FOR DETECTING GLAUCOMA AND RETINAL DISEASES           82

TABLE 13              CASE STUDY 2: INDIA’S NATIONAL PROGRAM FOR CONTROL OF BLINDNESS (NPCB) TO COLLABORATE WITH FORUS HEALTH FOR REDUCING

AVOIDABLE BLINDNESS               82

TABLE 14              CASE STUDY 3: UK NATIONAL HEALTH SERVICE TO DEPLOY HEIDELBERG ENGINEERING’S SPECTRALIS OCT PLATFORM FOR IMPROVING EARLY DETECTION OF CHRONIC DISEASES             83

TABLE 15              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  83

TABLE 16              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  84

TABLE 17              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  84

TABLE 18              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  85

TABLE 19              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  85

TABLE 20              OPHTHALMIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 89

TABLE 21              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS (%) 91

TABLE 22              KEY BUYING CRITERIA FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS      92

TABLE 23              US-ADJUSTED RECIPROCAL TARIFF RATES                 95

TABLE 24              KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR OPHTHALMIC IMAGING     96

TABLE 25              OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            100

TABLE 26              R&D ACTIVITIES IN AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT  101

TABLE 27              EXAMPLES OF AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT AVAILABLE

IN MARKET         102

TABLE 28              AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            103

TABLE 29              EXAMPLES OF NON-AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT AVAILABLE

IN MARKET         104

TABLE 30              NON-AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)             105

TABLE 31             OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            107

TABLE 32              OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            108

TABLE 33              OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            108

TABLE 34              OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY REGION,

2023–2030 (UNITS)            109

TABLE 35              EXAMPLES OF SPECTRAL-DOMAIN OCT (SD-OCT) AVAILABLE IN MARKET     109

TABLE 36              SPECTRAL-DOMAIN OCT (SD-OCT) MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 37              EXAMPLES OF SWEPT-SOURCE OCT (SS-OCT) AVAILABLE IN MARKET 111

TABLE 38              SWEPT-SOURCE OCT (SS-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     111

TABLE 39              EXAMPLES OF HANDHELD OCT AVAILABLE IN MARKET               112

TABLE 40              HANDHELD OCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       113

TABLE 41              OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            114

TABLE 42              OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 43              OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS)               115

TABLE 44              EXAMPLES OF OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS AVAILABLE

IN MARKET         115

TABLE 45              OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 46              EXAMPLES OF OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS AVAILABLE

IN MARKET         117

TABLE 47              OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          117

TABLE 48              EXAMPLES OF OPHTHALMIC ULTRASOUND BIOMICROSCOPES AVAILABLE

IN MARKET         118

TABLE 49              OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            119

TABLE 50              EXAMPLES OF OPHTHALMIC PACHYMETERS AVAIALBLE IN MARKET 120

TABLE 51              OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     120

TABLE 52              EXAMPLES OF OTHER OPHTHALMIC ULTRASOUND SYSTEMS AVAILABLE

IN MARKET         121

TABLE 53              OTHER OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 54              FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 123

TABLE 55              FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            123

TABLE 56              FUNDUS CAMERAS MARKET, BY REGION, 2023–2030 (UNITS)      124

TABLE 57              EXAMPLES OF MYDRIATIC FUNDUS CAMERAS AVAILABLE IN MARKET 125

TABLE 58              MYDRIATIC FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     125

TABLE 59              EXAMPLES OF NON-MYDRIATIC FUNDUS CAMERAS AVAILABLE IN MARKET            126

TABLE 60              NON-MYDRIATIC FUNDUS CAMERAS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            127

TABLE 61              EXAMPLES OF HYBRID FUNDUS CAMERAS AVAILABLE IN MARKET 128

TABLE 62              HYBRID FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     128

TABLE 63              EXAMPLES OF ROP FUNDUS CAMERAS AVAILABLE IN MARKET 129

TABLE 64              ROP FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            130

TABLE 65              SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)            131

TABLE 66              SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131

TABLE 67              SLIT LAMPS MARKET, BY REGION, 2023–2030 (UNITS)                132

TABLE 68              EXAMPLES OF HANDHELD SLIT LAMPS AVAILABLE IN MARKET 133

TABLE 69             HANDHELD SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            133

TABLE 70              EXAMPLES OF TABLE MOUNT SLIT LAMPS AVAILABLE IN MARKET 134

TABLE 71              TABLE MOUNT SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     135

TABLE 72              SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     136

TABLE 73              SPECULAR MICROSCOPES MARKET, BY REGION, 2023–2030 (UNITS)            136

TABLE 74              TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137

TABLE 75              TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       138

TABLE 76              TONOMETERS MARKET, BY REGION, 2023–2030 (UNITS)                138

TABLE 77              EXAMPLES OF APPLANATION TONOMETERS AVAILABLE IN MARKET 139

TABLE 78              APPLANATION TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     140

TABLE 79              EXAMPLES OF REBOUND TONOMETERS AVAILABLE IN MARKET 141

TABLE 80              REBOUND TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     141

TABLE 81              OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)       142

TABLE 82              OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            143

TABLE 83              OPHTHALMOSCOPES MARKET, BY REGION, 2023–2030 (UNITS)            143

TABLE 84              EXAMPLES OF DIRECT OPHTHALMOSCOPES AVAILABLE IN MARKET 144

TABLE 85              DIRECT OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     145

TABLE 86              EXAMPLES OF INDIRECT OPHTHALMOSCOPES AVAILABLE IN MARKET 146

TABLE 87              INDIRECT OPHTHALMOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 88              EXAMPLES OF RETINOSCOPES AVAILABLE IN MARKET               147

TABLE 89              RETINOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       148

TABLE 90              RETINOSCOPES MARKET, BY REGION, 2023–2030 (UNITS)                148

TABLE 91              EXAMPLES OF OTHER OPHTHALMIC IMAGING PRODUCTS AVAILABLE IN MARKET        149

TABLE 92              OTHER OPHTHALMIC IMAGING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            150

TABLE 93              OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              152

TABLE 94              OPHTHALMIC IMAGING MARKET FOR GLAUCOMA, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 95              OPHTHALMIC IMAGING MARKET FOR CATARACTS, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 96              OPHTHALMIC IMAGING MARKET FOR RETINOPATHIES, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 97              OPHTHALMIC IMAGING MARKET FOR REFRACTIVE DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)            156

TABLE 98              OPHTHALMIC IMAGING MARKET FOR AGE-RELATED MACULAR DEGENERATION,

BY COUNTRY, 2023–2030 (USD MILLION)               157

TABLE 99              OPHTHALMIC IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            158

TABLE 100          OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)            160

TABLE 101            OPHTHALMIC IMAGING MARKET FOR HOSPITALS, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 102            OPHTHALMIC IMAGING MARKET FOR OPHTHALMOLOGY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            162

TABLE 103            OPHTHALMIC IMAGING MARKET FOR OPTOMETRY CLINICS, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 104            OPHTHALMIC IMAGING MARKET FOR OTHER END USERS, BY COUNTRY,

2023–2030 (USD MILLION)            164

TABLE 105            OPHTHALMIC IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)            166

TABLE 106            NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 107            NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            168

TABLE 108            NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            169

TABLE 109            NORTH AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         169

TABLE 110            NORTH AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 111            NORTH AMERICA: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 112            NORTH AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)                170

TABLE 113            NORTH AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                171

TABLE 114            NORTH AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            171

TABLE 115            NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            171

TABLE 116            NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            172

TABLE 117            US: KEY MACROINDICATORS     172

TABLE 118            US: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            173

TABLE 119            US: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     173

TABLE 120            US: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            174

TABLE 121            US: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            174

TABLE 122            US: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)       175

TABLE 123            US: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175

TABLE 124            US: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175

TABLE 125            US: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            176

TABLE 126            US: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              176

TABLE 127            US: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)                176

TABLE 128            CANADA: KEY MACROINDICATORS         177

TABLE 129            CANADA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            177

TABLE 130            CANADA: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            178

TABLE 131            CANADA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         178

TABLE 132            CANADA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            179

TABLE 133            CANADA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            179

TABLE 134            CANADA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       179

TABLE 135            CANADA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            180

TABLE 136            CANADA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                180

TABLE 137            CANADA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            180

TABLE 138            CANADA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            181

TABLE 139            EUROPE: OPHTHALMIC IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            182

TABLE 140            EUROPE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            182

TABLE 141            EUROPE: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            183

TABLE 142            EUROPE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         183

TABLE 143            EUROPE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            184

TABLE 144            EUROPE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            184

TABLE 145            EUROPE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       184

TABLE 146            EUROPE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            185

TABLE 147            EUROPE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                185

TABLE 148            EUROPE: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)          185

TABLE 149            EUROPE: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)          186

TABLE 150            GERMANY: KEY MACROINDICATORS      187

TABLE 151            GERMANY: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            187

TABLE 152            GERMANY: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            187

TABLE 153            GERMANY: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)            188

TABLE 154            GERMANY: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            188

TABLE 155            GERMANY: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)                189

TABLE 156            GERMANY: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       189

TABLE 157            GERMANY: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            189

TABLE 158            GERMANY: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                190

TABLE 159            GERMANY: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            190

TABLE 160            GERMANY: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            190

TABLE 161            FRANCE: KEY MACROINDICATORS          191

TABLE 162            FRANCE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            191

TABLE 163            FRANCE: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            192

TABLE 164            FRANCE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            192

TABLE 165            FRANCE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            193

TABLE 166            FRANCE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            193

TABLE 167            FRANCE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       193

TABLE 168            FRANCE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            194

TABLE 169            FRANCE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                194

TABLE 170            FRANCE: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            194

TABLE 171            FRANCE: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            195

TABLE 172            UK: KEY MACROINDICATORS     195

TABLE 173            UK: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            196

TABLE 174            UK: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     196

TABLE 175            UK: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 176            UK: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 177            UK: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)       198

TABLE 178            UK: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198

TABLE 179            UK: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198

TABLE 180            UK: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            199

TABLE 181            UK: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              199

TABLE 182            UK: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)                199

TABLE 183            ITALY: KEY MACROINDICATORS               200

TABLE 184            ITALY: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            200

TABLE 185            ITALY: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     201

TABLE 186            ITALY: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            201

TABLE 187            ITALY: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            202

TABLE 188            ITALY: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            202

TABLE 189            ITALY: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202

TABLE 190            ITALY: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)       203

TABLE 191            ITALY: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            203

TABLE 192            ITALY: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            203

TABLE 193            ITALY: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)     204

TABLE 194            SPAIN: KEY MACROINDICATORS               204

TABLE 195            SPAIN: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            205

TABLE 196            SPAIN: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     205

TABLE 197            SPAIN: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            206

TABLE 198            SPAIN: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            206

TABLE 199            SPAIN: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            207

TABLE 200            SPAIN: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207

TABLE 201            SPAIN: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)       207

TABLE 202            SPAIN: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            208

TABLE 203            SPAIN: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            208

TABLE 204            SPAIN: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            208

TABLE 205            REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            209

TABLE 206            REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            210

TABLE 207            REST OF EUROPE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         210

TABLE 208            REST OF EUROPE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         211

TABLE 209            REST OF EUROPE: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            211

TABLE 210            REST OF EUROPE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)                211

TABLE 211            REST OF EUROPE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                212

TABLE 212            REST OF EUROPE: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            212

TABLE 213            REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            212

TABLE 214            REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            213

TABLE 215          ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            215

TABLE 216          ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            215

TABLE 217          ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            216

TABLE 218            ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)            216

TABLE 219            ASIA PACIFIC: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            217

TABLE 220            ASIA PACIFIC: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)                217

TABLE 221            ASIA PACIFIC: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)            217

TABLE 222            ASIA PACIFIC: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            218

TABLE 223            ASIA PACIFIC: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)         218

TABLE 224          ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            218

TABLE 225          ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            219

TABLE 226            JAPAN: KEY MACROINDICATORS              219

TABLE 227            JAPAN: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            220

TABLE 228            JAPAN: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     220

TABLE 229            JAPAN: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         221

TABLE 230            JAPAN: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            221

TABLE 231            JAPAN: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            222

TABLE 232            JAPAN: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       222

TABLE 233            JAPAN: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)       222

TABLE 234          JAPAN: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            223

TABLE 235            JAPAN: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            223

TABLE 236            JAPAN: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            223

TABLE 237            CHINA: KEY MACROINDICATORS             224

TABLE 238            CHINA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            224

TABLE 239            CHINA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     225

TABLE 240            CHINA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            225

TABLE 241            CHINA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            226

TABLE 242            CHINA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            226

TABLE 243            CHINA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       226

TABLE 244            CHINA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)       227

TABLE 245          CHINA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            227

TABLE 246            CHINA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            227

TABLE 247            CHINA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            228

TABLE 248            INDIA: KEY MACROINDICATORS               228

TABLE 249            INDIA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            229

TABLE 250            INDIA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     229

TABLE 251            INDIA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         230

TABLE 252            INDIA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            230

TABLE 253            INDIA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            231

TABLE 254            INDIA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231

TABLE 255            INDIA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)       231

TABLE 256            INDIA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            232

TABLE 257            INDIA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            232

TABLE 258            INDIA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)     232

TABLE 259            SOUTH KOREA: KEY MACROINDICATORS                 233

TABLE 260            SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            233

TABLE 261            SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            234

TABLE 262            SOUTH KOREA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         234

TABLE 263            SOUTH KOREA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            235

TABLE 264            SOUTH KOREA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)                235

TABLE 265            SOUTH KOREA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)            235

TABLE 266            SOUTH KOREA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                236

TABLE 267            SOUTH KOREA: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            236

TABLE 268            SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            236

TABLE 269            SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            237

TABLE 270            AUSTRALIA: KEY MACROINDICATORS   237

TABLE 271            AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            238

TABLE 272            AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            238

TABLE 273            AUSTRALIA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)            239

TABLE 274            AUSTRALIA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            239

TABLE 275            AUSTRALIA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)                240

TABLE 276            AUSTRALIA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)            240

TABLE 277            AUSTRALIA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            240

TABLE 278            AUSTRALIA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                241

TABLE 279            AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            241

TABLE 280            AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            241

TABLE 281            REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            242

TABLE 282            REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            243

TABLE 283            REST OF ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         243

TABLE 284            REST OF ASIA PACIFIC: OPHTHALMIC ULTRASOUND SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         244

TABLE 285            REST OF ASIA PACIFIC: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            244

TABLE 286            REST OF ASIA PACIFIC: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)                244

TABLE 287            REST OF ASIA PACIFIC: TONOMETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            245

TABLE 288            REST OF ASIA PACIFIC: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            245

TABLE 289            REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            245

TABLE 290            REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            246

TABLE 291            LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            247

TABLE 292            LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            247

TABLE 293            LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            248

TABLE 294            LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         248

TABLE 295            LATIN AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            249

TABLE 296            LATIN AMERICA: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            249

TABLE 297          LATIN AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)            249

TABLE 298            LATIN AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                250

TABLE 299            LATIN AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            250

TABLE 300            LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            250

TABLE 301            LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            251

TABLE 302            BRAZIL: KEY MACROINDICATORS            251

TABLE 303            BRAZIL: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            252

TABLE 304            BRAZIL: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            252

TABLE 305            BRAZIL: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            253

TABLE 306            BRAZIL: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            253

TABLE 307            BRAZIL: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            254

TABLE 308            BRAZIL: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       254

TABLE 309            BRAZIL: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)       254

TABLE 310            BRAZIL: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                255

TABLE 311            BRAZIL: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            255

TABLE 312            BRAZIL: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)          255

TABLE 313            MEXICO: KEY MACROINDICATORS          256

TABLE 314            MEXICO: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            256

TABLE 315            MEXICO: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            257

TABLE 316            MEXICO: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            257

TABLE 317            MEXICO: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            258

TABLE 318            MEXICO: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)            258

TABLE 319            MEXICO: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)       258

TABLE 320            MEXICO: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            259

TABLE 321            MEXICO: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                259

TABLE 322            MEXICO: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            259

TABLE 323            MEXICO: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            260

TABLE 324            REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            260

TABLE 325            REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            261

TABLE 326            REST OF LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)       261

TABLE 327            REST OF LATIN AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)            262

TABLE 328            REST OF LATIN AMERICA: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            262

TABLE 329            REST OF LATIN AMERICA: SLIT LAMPS MARKET, BY TYPE,

2023–2030 (USD MILLION)            262

TABLE 330            REST OF LATIN AMERICA: TONOMETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            263

TABLE 331            REST OF LATIN AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            263

TABLE 332            REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)                 263

TABLE 333            REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            264

TABLE 334            MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            265

TABLE 335            MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 265

TABLE 336            MIDDLE EAST & AFRICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)            266

TABLE 337            MIDDLE EAST & AFRICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)            266

TABLE 338            MIDDLE EAST & AFRICA: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 339            MIDDLE EAST & AFRICA: SLIT LAMPS MARKET, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 340            MIDDLE EAST & AFRICA: TONOMETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 341            MIDDLE EAST & AFRICA: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            268

TABLE 342            MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            268

TABLE 343            MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            269

TABLE 344            GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            270

TABLE 345            GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            270

TABLE 346            GCC COUNTRIES: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         271

TABLE 347            GCC COUNTRIES: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,

2023–2030 (USD MILLION)            271

TABLE 348            GCC COUNTRIES: FUNDUS CAMERAS MARKET, BY TYPE,

2023–2030 (USD MILLION)            272

TABLE 349            GCC COUNTRIES: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)                272

TABLE 350            GCC COUNTRIES: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                272

TABLE 351            GCC COUNTRIES: OPHTHALMOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 352            GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            273

TABLE 353            GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            273

TABLE 354            KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS IN OPHTHALMIC IMAGING MARKET, JANUARY 2021–JULY 2025             274

TABLE 355            OPHTHALMIC IMAGING MARKET: DEGREE OF COMPETITION 277

TABLE 356            OPHTHALMIC IMAGING MARKET: REGION FOOTPRINT       281

TABLE 357            OPHTHALMIC IMAGING MARKET: PRODUCT FOOTPRINT       282

TABLE 358            OPHTHALMIC IMAGING MARKET: APPLICATION FOOTPRINT         283

TABLE 359            OPHTHALMIC IMAGING MARKET: END-USER FOOTPRINT       284

TABLE 360            OPHTHALMIC IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS  287

TABLE 361            OPHTHALMIC IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY APPLICATION AND REGION 288

TABLE 362            OPHTHALMIC IMAGING MARKET: PRODUCT LAUNCHES,

JANUARY 2021–JULY 2025               291

TABLE 363            OPHTHALMIC IMAGING MARKET: DEALS, JANUARY 2021–JULY 2025               292

TABLE 364            OPHTHALMIC IMAGING MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JULY 2025               292

TABLE 365            CARL ZEISS MEDITEC AG: COMPANY OVERVIEW                 293

TABLE 366            CARL ZEISS MEDITEC AG: PRODUCTS OFFERED                 294

TABLE 367            CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES & UPGRADES,

JANUARY 2021–JULY 2025               295

TABLE 368            CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021–JULY 2025  295

TABLE 369            TOPCON CORPORATION: COMPANY OVERVIEW          297

TABLE 370            TOPCON CORPORATION: PRODUCTS OFFERED                 298

TABLE 371            TOPOCON CORPORATION: DEALS, JANUARY 2021–JULY 2025  299

TABLE 372            TOPOCON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2025          299

TABLE 373            NIDEK CO., LTD.: COMPANY OVERVIEW                 301

TABLE 374            NIDEK CO., LTD.: PRODUCTS OFFERED 301

TABLE 375            HALMA PLC: COMPANY OVERVIEW         303

TABLE 376            HALMA PLC: PRODUCTS OFFERED          305

TABLE 377            ALCON: COMPANY OVERVIEW  307

TABLE 378            ALCON: PRODUCTS OFFERED   308

TABLE 379            HEIDELBERG ENGINEERING GMBH: COMPANY OVERVIEW          310

TABLE 380            HEIDELBERG ENGINEERING GMBH: PRODUCTS OFFERED             310

TABLE 381            HAAG-STREIT GROUP: COMPANY OVERVIEW                 311

TABLE 382            HAAG-STREIT GROUP: PRODUCTS OFFERED                 311

TABLE 383            CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW   312

TABLE 384            CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED    313

TABLE 385            ESSILORLUXOTTICA: COMPANY OVERVIEW                 314

TABLE 386            ESSILORLUXOTTICA: PRODUCTS OFFERED                 314

TABLE 387            OCULUS: COMPANY OVERVIEW                315

TABLE 388            OCULUS: PRODUCTS OFFERED 315

TABLE 389            OCULUS: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025             316

TABLE 390            VISIONIX: COMPANY OVERVIEW               317

TABLE 391            VISIONIX: PRODUCTS OFFERED                317

TABLE 392            VISIONIX: DEALS, JANUARY 2021–JULY 2025                 318

TABLE 393            SONOMED ESCALON: COMPANY OVERVIEW                 319

TABLE 394            SONOMED ESCALON: PRODUCTS OFFERED                 319

TABLE 395            COBURN TECHNOLOGIES, INC.: COMPANY OVERVIEW          320

TABLE 396            COBURN TECHNOLOGIES, INC.: PRODUCTS OFFERED             320

TABLE 397            COBURN TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025     321

TABLE 398            DGH TECHNOLOGY, INC.: COMPANY OVERVIEW          322

TABLE 399            DGH TECHNOLOGY, INC.: PRODUCTS OFFERED                 322

TABLE 400            SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.:

COMPANY OVERVIEW   323

TABLE 401            SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.:

PRODUCTS OFFERED    323

TABLE 402            VISUNEX MEDICAL SYSTEMS: COMPANY OVERVIEW          324

TABLE 403            FORUS HEALTH PVT. LTD.: COMPANY OVERVIEW          325

TABLE 404            ZIEMER OPHTHALMIC SYSTEMS AG: COMPANY OVERVIEW          326

TABLE 405            EYENUK INC.: COMPANY OVERVIEW      327

TABLE 406            COSTRUZIONE STRUMENTI OFTALMICI (CSO): COMPANY OVERVIEW   328

TABLE 407            HAI LABORATORIES, INC.: COMPANY OVERVIEW          329

TABLE 408            CRYSTALVUE MEDICAL CORPORATION: COMPANY OVERVIEW   330

TABLE 409            SUZHOU KANGJIE MEDICAL INC.: COMPANY OVERVIEW          331

TABLE 410            KONAN MEDICAL USA, INC.: COMPANY OVERVIEW          332

TABLE 411            REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.: COMPANY OVERVIEW   333

LIST OF FIGURES

FIGURE 1              OPHTHALMIC IMAGING MARKET SEGMENTATION & REGIONAL SCOPE    34

FIGURE 2              OPHTHALMIC IMAGING MARKET: YEARS CONSIDERED    36

FIGURE 3              OPHTHALMIC IMAGING MARKET: RESEARCH DESIGN                38

FIGURE 4              OPHTHALMIC IMAGING MARKET: KEY DATA FROM SECONDARY SOURCES    40

FIGURE 5              OPHTHALMIC IMAGING MARKET: KEY PRIMARY DATA SOURCES            40

FIGURE 6              OPHTHALMIC IMAGING MARKET: KEY DATA FROM PRIMARY SOURCES            41

FIGURE 7              OPHTHALMIC IMAGING MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS     42

FIGURE 8              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND

DEMAND-SIDE PARTICIPANTS  42

FIGURE 9              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION            43

FIGURE 10            BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):

BY END USER, DESIGNATION, AND REGION        43

FIGURE 11            SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         44

FIGURE 12            REVENUE SHARE ANALYSIS ILLUSTRATION: CARL ZEISS MEDITEC AG (2024)                 45

FIGURE 13            OPHTHALMIC IMAGING SUPPLY-SIDE MARKET SIZE ESTIMATION (2024)               46

FIGURE 14            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)          47

FIGURE 15            OPHTHALMIC IMAGING MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)               48

FIGURE 16            OPHTHALMIC IMAGING MARKET: TOP-DOWN APPROACH         49

FIGURE 17            OPHTHALMIC IMAGING MARKET: DATA TRIANGULATION METHODOLOGY         50

FIGURE 18            OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)      53

FIGURE 19           OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)      54

FIGURE 20            OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)       55

FIGURE 21           OPHTHALMIC IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      55

FIGURE 22            REGIONAL SNAPSHOT OF OPHTHALMIC IMAGING MARKET           56

FIGURE 23            RISING ADOPTION OF ADVANCED OPHTHALMIC DIAGNOSTICS IN HOSPITALS TO BOOST DEMAND FOR INTEGRATED IMAGING SYSTEMS               57

FIGURE 24            CHINA AND NON-AI-ENABLED EQUIPMENT COMMANDED LARGEST

ASIA PACIFIC MARKET SHARE IN 2024     58

FIGURE 25            INDIA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 59

FIGURE 26            ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030              59

FIGURE 27            EMERGING MARKETS TO PROJECT HIGHER GROWTH RATES

DURING STUDY PERIOD               60

FIGURE 28            OPHTHALMIC IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          61

FIGURE 29            OPHTHALMIC IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING

CUSTOMERS’ BUSINESSES           67

FIGURE 30            AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD)    68

FIGURE 31            OPHTHALMIC IMAGING MARKET: VALUE CHAIN ANALYSIS              69

FIGURE 32            OPHTHALMIC IMAGING MARKET: SUPPLY CHAIN ANALYSIS              71

FIGURE 33            OPHTHALMIC IMAGING MARKET: ECOSYSTEM ANALYSIS            72

FIGURE 34            OPHTHALMIC IMAGING MARKET: FUNDING AND NUMBER OF DEALS,

2019–2023 (USD MILLION)            73

FIGURE 35            OPHTHALMIC IMAGING MARKET: VALUE OF INVESTOR DEALS,

BY KEY PLAYER, 2019–2023 (USD MILLION)           74

FIGURE 36            OPHTHALMIC IMAGING MARKET: NUMBER OF INVESTOR DEALS,

BY KEY PLAYER, 2019–2023 (UNITS)          74

FIGURE 37            OPHTHALMIC IMAGING MARKET: TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENT APPLIED/GRANTED, JANUARY 2015−JULY 2025 78

FIGURE 38            OPHTHALMIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 89

FIGURE 39            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS         91

FIGURE 40            KEY BUYING CRITERIA FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS      92

FIGURE 41            IMPACT OF AI/GEN AI ON OPHTHALMIC IMAGING MARKET           98

FIGURE 42            MARKETS ADJACENT TO OPHTHALMIC IMAGING MARKET           98

FIGURE 43            NORTH AMERICA: OPHTHALMIC IMAGING MARKET SNAPSHOT       167

FIGURE 44            ASIA PACIFIC: OPHTHALMIC IMAGING MARKET SNAPSHOT          214

FIGURE 45            REVENUE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC IMAGING MARKET,

2020–2024 (USD MILLION)            276

FIGURE 46            MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC

IMAGING MARKET (2024)              277

FIGURE 47            OPHTHALMIC IMAGING MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       279

FIGURE 48            OPHTHALMIC IMAGING MARKET: COMPANY FOOTPRINT       280

FIGURE 49            OPHTHALMIC IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 286

FIGURE 50            EV/EBITDA OF KEY VENDORS   289

FIGURE 51            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            289

FIGURE 52            OPHTHALMIC IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     290

FIGURE 53            CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT                 294

FIGURE 54            TOPCON CORPORATION: COMPANY SNAPSHOT          298

FIGURE 55            HALMA PLC: COMPANY SNAPSHOT        304

FIGURE 56            ALCON: COMPANY SNAPSHOT  307

FIGURE 57            CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT   313

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧